Nuveen Asset Management’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,503
| Closed | -$138K | – | 3345 |
|
|
2024
Q3 | $138K | Hold |
9,503
| – | – | ﹤0.01% | 3280 |
|
|
2024
Q2 | $693K | Hold |
9,503
| – | – | ﹤0.01% | 2882 |
|
|
2024
Q1 | $563K | Hold |
9,503
| – | – | ﹤0.01% | 2935 |
|
|
2023
Q4 | $696K | Hold |
9,503
| – | – | ﹤0.01% | 2889 |
|
|
2023
Q3 | $369K | Hold |
9,503
| – | – | ﹤0.01% | 2929 |
|
|
2023
Q2 | $548K | Buy |
+9,503
| New | +$548K | ﹤0.01% | 2883 |
|
|
2022
Q2 | – | Sell |
-3,279
| Closed | -$277K | – | 3408 |
|
|
2022
Q1 | $277K | Hold |
3,279
| – | – | ﹤0.01% | 3137 |
|
|
2021
Q4 | $297K | Hold |
3,279
| – | – | ﹤0.01% | 3181 |
|
|
2021
Q3 | $399K | Hold |
3,279
| – | – | ﹤0.01% | 3208 |
|
|
2021
Q2 | $371K | Hold |
3,279
| – | – | ﹤0.01% | 3195 |
|
|
2021
Q1 | $497K | Sell |
3,279
-1,426
| -30% | -$216K | ﹤0.01% | 3100 |
|
|
2020
Q4 | $542K | Buy |
4,705
+79
| +2% | +$9.1K | ﹤0.01% | 3025 |
|
|
2020
Q3 | $358K | Buy |
4,626
+395
| +9% | +$30.6K | ﹤0.01% | 3040 |
|
|
2020
Q2 | $466K | Sell |
4,231
-806
| -16% | -$88.8K | ﹤0.01% | 2929 |
|
|
2020
Q1 | $550K | Buy |
5,037
+410
| +9% | +$44.8K | ﹤0.01% | 2728 |
|
|
2019
Q4 | $735K | Buy |
4,627
+251
| +6% | +$39.9K | ﹤0.01% | 2796 |
|
|
2019
Q3 | $646K | Buy |
4,376
+2,377
| +119% | +$351K | ﹤0.01% | 2866 |
|
|
2019
Q2 | $232K | Buy |
+1,999
| New | +$232K | ﹤0.01% | 3146 |
|